{
    "pmcid": "11070728",
    "summary": "The paper \"HighFold: accurately predicting structures of cyclic peptides and complexes with head-to-tail and disulfide bridge constraints\" introduces HighFold, a novel computational model derived from AlphaFold, designed to predict the structures of cyclic peptides and their complexes. This model addresses the limitations of traditional experimental methods and existing computational approaches in predicting cyclic peptide structures, particularly those with head-to-tail cyclization and disulfide bridges. HighFold integrates specific structural constraints to enhance prediction accuracy, representing a significant advancement in the field of cyclic peptide structure prediction.\n\n### Key Insights on AlphaFold-Multimer in Relation to Designing SARS-CoV-2 Nanobody Binders:\n\n1. **AlphaFold-Multimer Framework**: HighFold utilizes the AlphaFold-Multimer framework to predict cyclic peptide complexes. This framework is crucial for modeling interactions between cyclic peptides and target proteins, which is essential for designing effective nanobody binders against SARS-CoV-2.\n\n2. **CycPOEM Matrix**: HighFold employs the Cyclic Position Offset Encoding Matrix (CycPOEM) to account for the cyclic nature and disulfide bridges in peptides. This matrix is crucial for accurately predicting the structural folds of cyclic peptides and their complexes, which can be applied to designing nanobody binders that require precise structural conformations to interact with the SARS-CoV-2 spike protein.\n\n3. **Disulfide Bridge Enumeration**: HighFold enumerates all possible disulfide bridge combinations, creating corresponding matrices in AlphaFold/AlphaFold-Multimer. This approach ensures accurate prediction of disulfide bridges, which are critical for the stability and binding affinity of nanobodies targeting the SARS-CoV-2 spike protein.\n\n4. **Performance Metrics**: HighFold ranks predicted structures based on confidence values such as pLDDT and Mconf, derived from AlphaFold and AlphaFold-Multimer. These metrics help in selecting the most reliable structural predictions, which is vital for identifying potential nanobody candidates with high binding affinity and specificity.\n\n5. **HighFold_Multimer**: This model, based on AlphaFold-Multimer, is specifically designed for predicting cyclic peptide complex structures. It includes both cyclic peptide ligands and target proteins, making it suitable for modeling nanobody interactions with the SARS-CoV-2 spike protein.\n\n6. **Benchmarking and Evaluation**: HighFold_Multimer demonstrates superior performance in predicting cyclic peptide complexes compared to existing methods like ADCP. Its ability to accurately predict complex structures with varying lengths and secondary structures highlights its potential in designing nanobodies for SARS-CoV-2.\n\n7. **Potential for Nanobody Design**: The ability of HighFold to predict cyclic peptide structures with high accuracy and without experimental structural data makes it a valuable tool for virtual screening and design of nanobodies. This capability is particularly relevant for rapidly developing therapeutic agents against emerging viral threats like SARS-CoV-2.\n\nIn summary, HighFold, through its integration with AlphaFold-Multimer, provides a robust framework for predicting cyclic peptide structures and their complexes, offering significant potential for designing nanobody binders against the SARS-CoV-2 spike protein. Its advanced predictive capabilities and consideration of structural constraints make it a promising tool for accelerating drug discovery and development in response to viral pandemics.",
    "title": "HighFold: accurately predicting structures of cyclic peptides and complexes with head-to-tail and disulfide bridge constraints"
}